Low-grade proteinuria is highly prevalent in HIV-positive patients on antiretroviral treatment

AIDS

Volumn 28, Issue 12, 2014, Pages 1783-1789

  Gravemann, Sophia ^b,d   Brinkkoetter, Paul T ^a,c   Vehreschild, Jörg J ^b,d   Franke, Bernd ^b   Ehren, Kathrin ^b   Bünemann, Elisabeth ^b   Orbach, Henning ^b   Wei, Verena ^c   Hellmich, Martin ^c   Benzing, Thomas ^a,c,e   Fätkenheuer, Gerd ^b,d  

^a Department II of Internal Medicine ^*  (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d German Center for Infection Research (DZIF)   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

Author keywords

albuminuria; HIV; proteinuria; tenofovir; tubular proteinuria

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CREATININE; PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ALBUMINS; ALPHA-MACROGLOBULINS; ANTI-RETROVIRAL AGENTS;

ADULT; AGE; AGED; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG EXPOSURE; FEMALE; GLOMERULAR PROTEINURIA; GLOMERULUS FILTRATION RATE; HEPATITIS C VIRUS; HETEROSEXUALITY; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIXED INFECTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; QUANTITATIVE ANALYSIS; TUBULAR PROTEINURIA; URINALYSIS; CHEMISTRY; COMPLICATION; CROSS-SECTIONAL STUDIES; GERMANY; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MIDDLE AGED; PATHOLOGY; PREVALENCE; RISK FACTORS; URINE;

ADULT; AGED; ALBUMINS; ALPHA-MACROGLOBULINS; ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROTEINURIA; RISK FACTORS; URINE;

EID: 84904209376     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000324     Document Type: Article

References (41)

1. Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, et al. Inferior clinical outcome of the CD4R cell countguided antiretroviral treatment interruption strategy in the SMART study role of CD4R cell counts and HIV RNA levels during follow-up. J Infect Dis 2008 1971145-1155.
2. Wyatt CM, Hoover DR, Shi Q, Tien PC, Karim R, Cohen MH, et al. Preexisting albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther 2011 16591-596.
3. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 2010 121651-658.
4. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol 1998 11239-245.
5. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998 9S16-S23.
6. Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003 4111-17.
7. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003 421050-1065.
8. Scherzer R, Estrella M, Li Y, Choi AI, Deeks SG, Grunfeld C, et al. Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS 2012 26867-875.
9. Sax PE, Tierney C, Collier AC, Daar ES, Mollan K, Budhathoki C, et al. Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV final results. J Infect Dis 2011 2041191-1201.
10. Flandre P, Pugliese P, Cuzin L, Bagnis CI, Tack I, Cabie A, et al. Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol 2011 61700-1707.
11. Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010 241667-1678.
12. Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003 33506-512.
13. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005 35248-62.
14. Triant VA. HIV infection and coronary heart disease an intersection of epidemics. J Infect Dis 2012 205 (Suppl 3)S355-S361.
15. Medapalli RK, He JC, Klotman PE. HIV-associated nephropathy pathogenesis. Curr Opin Nephrol Hypertens 2011 20306-311.
16. George E, Nadkarni GN, Estrella MM, Lucas GM, Sperati CJ, Atta MG, et al. The impact of hepatitis C coinfection on kidney disease related to human immunodeficiency virus (HIV) a biopsy study. Medicine (Baltimore) 2011 90289-295.
17. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004 661145-1152.
18. Cheng JT, Anderson HL Jr, Markowitz GS, Appel GB, Pogue VA, D'Agati VD. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999 101566-1574.
19. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991 3241457-1463.
20. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy a 12-year cohort study. AIDS 2004 18541-546.
21. Ryom L, Mocroft A, Kirk O, Ross M, Reiss P, Fux CA, et al. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. AIDS 2014 28187-199.
22. Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, et al. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe. HIV Med 2013 14503-508.
23. Hofmann W, Guder WG. A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989 27589-600.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130461-470.
25. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009 150604-612.
26. Ando M, Yanagisawa N, Ajisawa A, Tsuchiya K, Nitta K. Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients. Nephrol Dial Transplant 2011 263923-3929.
27. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative NKF KDOQITM (by The National Kidney Foundation, Inc.). Evidence-based clinical practice guideline for all stages of CKD http//www.kidney.org/professionals/ KDOQI/28.
28. Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der Horst C, Sidney S, et al. Microalbuminuria in HIV infection. AIDS 2007 211003-1009.
29. Reynes J, Cournil A, Peyriere H, Psomas C, Guiller E, Chatron M, et al. Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate >-60 ml/min per 1.73m2. AIDS 2013 271295-1302.
30. Kim PS, Woods C, Dutcher L, Georgoff P, Rosenberg A, Mican JA, et al. Increased prevalence of albuminuria in HIV-infected adults with diabetes. PLoS One 2011 6e24610.
31. Szczech LA, Menezes P, Byrd Quinlivan E, van der Horst C, Bartlett JA, Svetkey LP. Microalbuminuria predicts overt proteinuria among patients with HIV infection. HIV Med 2010 11419-426.
32. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals the Framingham Heart Study. Circulation 2005 112969-975.
33. Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc 2008 83806-812.
34. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts a collaborative meta-analysis. Lancet 2010 3752073-2081.
35. Choi A, Scherzer R, Bacchetti P, Tien PC, Saag MS, Gibert CL, et al. Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis 2010 56872-882.
36. Campbell LJ, Dew T, Salota R, Cheserem E, Hamzah L, Ibrahim F, et al. Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients. BMC Nephrol 2012 1385.
37. Hadigan C, Edwards E, Rosenberg A, Purdy JB, Fleischman E, Howard L, et al. Microalbuminuria in HIV disease. Am J Nephrol 2013 37443-451.
38. Msango L, Downs JA, Kalluvya SE, Kidenya BR, Kabangila R, Johnson WD Jr, et al. Renal dysfunction among HIVinfected patients starting antiretroviral therapy. AIDS 2011 251421-1425.
39. Wyatt CM, Hoover DR, Shi Q, Seaberg E, Wei C, Tien PC, et al. Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr 2010 5573-77.
40. Nishijima T, ShimboT,KomatsuH, TakanoM,Tanuma J, Tsukada K, et al. Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection a diagnostic accuracy study. J Infect Chemother 2013 19850-857.
41. Ryom L, Mocroft A, Lundgren J. HIV therapies and the kidney some good, some not so good? Curr HIV/AIDS Rep 2012 9111-120.